However, the clinical effect of PD-1/PD-L1 inhibitor monotherapy in the treatment of immunogenically “cold” tumors like breast cancer is not ideal, and it is often used in combination with chemoradiotherapy [6]. The gene discussed is CD274; the disease is breast carcinoma.